Literature DB >> 17321986

Successful allogeneic stem cell transplantation for an adult with refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

Chao-Hsun Chen1, Shan-Wen Chen, Wan-Lin Shen, Tsai-Yun Chen, Chao-Jung Tsao, Wen-Tsung Huang.   

Abstract

Anaplastic lymphoma kinase (ALK) expression exists in approximately 60% of anaplastic large cell lymphoma (ALCL) cases. Compared with the ALK-negative cases, ALK-positive cases are usually characterized by a good response to chemotherapy and a good prognosis. In the relapsed or refractory ALCL cases, high-dose chemotherapy followed by autologous stem cell transplantation has been widely used as a salvage therapy. However, 40% of patients who received transplants after more than 2 complete remissions eventually experienced disease progression, despite receiving autologous stem cell transplantation. Allogeneic stem cell transplantation has been proposed as a therapeutic option in refractory ALCL cases, but clinical reports of adult patients are rare. Herein, we report the case of an adult with refractory ALK-positive ALCL who was successfully treated with salvage high-dose chemotherapy followed by allogeneic stem cell transplantation.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17321986     DOI： 10.1532/IJH97.A10608

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  17 in total

Review 1.  Anaplastic large cell lymphoma: pathological, molecular and clinical features.

Authors:  B Falini
Journal:  Br J Haematol       Date:  2001-09       Impact factor: 6.998

2.  Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT).

Authors:  R Fanin; M C Ruiz de Elvira; A Sperotto; M Baccarani; A Goldstone
Journal:  Bone Marrow Transplant       Date:  1999-03       Impact factor: 5.483

3.  Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma.

Authors:  Arcangelo Liso; Enrico Tiacci; Roberto Binazzi; Karen Pulford; Roberta Benedetti; Alessandra Carotti; Franco Aversa; Brunangelo Falini
Journal:  Lancet Oncol       Date:  2004-02       Impact factor: 41.316

4.  Successful treatment with allogeneic bone marrow transplantation of an early relapse of ALK-positive anaplastic large cell lymphoma.

Authors:  Victoria Bordon; Pascale De Paepe; Catharina Dhooge; Els Vandecruys; Yves Benoit; Genevieve Laureys
Journal:  Haematologica       Date:  2005-03       Impact factor: 9.941

5.  Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma.

Authors:  L Mussolin; M Pillon; E S d'Amore; N Santoro; A Lombardi; F Fagioli; L Zanesco; A Rosolen
Journal:  Leukemia       Date:  2005-09       Impact factor: 11.528

6.  Bone marrow transplantation for childhood Ki-1 lymphoma.

Authors:  V Chakravarti; N R Kamani; E Bayever; B Lange; P Herzog; J E Sanders; C S August
Journal:  J Clin Oncol       Date:  1990-04       Impact factor: 44.544

7.  Ki-1 lymphoma in two children.

Authors:  Y H Yang; S T Jou; D T Lin; M Y Lu; K H Lin; I J Su
Journal:  J Formos Med Assoc       Date:  1998-02       Impact factor: 3.282

8.  Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children--a report from the French Society of Pediatric Oncology.

Authors:  L Brugières; P Quartier; M C Le Deley; H Pacquement; Y Perel; C Bergeron; C Schmitt; J Landmann; C Patte; M J Terrier-Lacombe; G Delsol; O Hartmann
Journal:  Ann Oncol       Date:  2000-01       Impact factor: 32.976

9.  Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous bone marrow transplantation.

Authors:  R Fanin; F Silvestri; A Geromin; M Cerno; L Infanti; F Zaja; G Barillari; C Savignano; C Rinaldi; D Damiani; A Buffoli; F Biffoni; M Baccarini
Journal:  Blood       Date:  1996-02-15       Impact factor: 22.113

10.  Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.

Authors:  M Shiota; S Nakamura; R Ichinohasama; M Abe; T Akagi; M Takeshita; N Mori; J Fujimoto; J Miyauchi; A Mikata; K Nanba; T Takami; H Yamabe; Y Takano; T Izumo; T Nagatani; N Mohri; K Nasu; H Satoh; H Katano; J Fujimoto; T Yamamoto; S Mori
Journal:  Blood       Date:  1995-09-01       Impact factor: 22.113
View more
  1 in total

1.  Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning for a child with recurrent anaplastic large cell lymphoma.

Authors:  Hideaki Ohta; Shigenori Kusuki; Hisao Yoshida; Emiko Sato; Yoshiko Hashii; Keiichi Ozono
Journal:  Int J Hematol       Date:  2010-06-15       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.